Outlook Therapeutics (OTLK) Return on Capital Employed [ROCE] (2016 - 2024)
Outlook Therapeutics (OTLK) recorded Return on Capital Employed [ROCE] of -583.31% in fiscal Q3 2024 (quarter ended Jun 30, 2024).
Powered by 
Analysis
Outlook Therapeutics (OTLK) Return on Capital Employed [ROCE] (2016 - 2024) Analysis & Trends
For FY2022 (ended Sep 30, 2022), Outlook Therapeutics reported Return on Capital Employed [ROCE] of -1061.83%, down 705.58 percentage points from FY2021.
- Across earlier fiscal years, Return on Capital Employed [ROCE] came in at -356.25% in FY2021 (+1091.34 pp) and -1447.59% in FY2020.
- The fiscal Q3 2024 figure is the highest quarterly Return on Capital Employed [ROCE] since fiscal Q2 2023.
- Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 965.51 percentage points in fiscal Q3 2021, against a drop of 224.67 percentage points in fiscal Q2 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Outlook Therapeutics | 62.90 Mn | 27.15 Mn | -8,265.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -583.31% |
| Mar 31, 2023 | -361.05% |
| Dec 31, 2022 | -214.93% |
| Sep 30, 2022 | -456.11% |
| Jun 30, 2022 | -180.13% |
| Mar 31, 2022 | -136.39% |
| Dec 31, 2021 | -164.58% |
| Sep 30, 2021 | -245.21% |
| Jun 30, 2021 | -249.53% |
| Mar 31, 2021 | -990.61% |
| Dec 31, 2020 | -1,070.67% |
| Sep 30, 2020 | -404.89% |
| Jun 30, 2020 | -1,215.04% |
| Sep 30, 2019 | -743.17% |
| Jun 30, 2019 | -1,823.61% |
| Sep 30, 2016 | -586.00% |
| Jun 30, 2016 | -983.54% |
API Access
Outlook Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();